Epidemiology and Comorbidity
Phobias are among the most common psychiatric disorders. Findings based
on large community samples from five sites in the Epidemiological Catchment
Area (ECA) study (Eaton et al., 1991)
yielded lifetime prevalence estimates of 11.25% for specific phobias and 2.73%
for social phobia. Estimates from the National Comorbidity Survey (NCS)
(Kessler et al., 1994) were
consistent with previous findings on specific phobias: a lifetime prevalence of
11.30% in a sample of more than 8000 individuals from across the USA. The
recent NCS-Replication study found lifetime prev-alence rates of 12.5% and 12.1
respectively for specific phobia and social phobia (Kessler et al., 2005).
Specific phobias are more common in women than in men, although there are differences in sex ratio among phobia types. Specifically, the ratio of females to males is smaller for height phobias than for other specific phobia types. Among social pho-bia situations, sex differences are less pronounced than for most specific phobia types. In the NCS, relatively small sex differ-ences in social phobia prevalence were confirmed, with lifetime estimates of 11.1% for males and 15.5% for females. In addition, the relatively equal numbers of men and women with social pho-bia in epidemiological studies is consistent with findings from samples of individuals presenting for treatment.
Most studies have found the mean age at onset of social phobia to be in
the middle to late teens. This is supported by research finding that social
phobia is common in children and is diagnosed in a significant percentage of
children referred to a specialty anxiety disorders clinic. A history of
childhood anxiety has been associated with an earlier age of onset of social
phobia as well as greater severity and comorbidity. Mean age at onset for
specific phobias appears to differ depending on the type of pho-bia. Phobias of
animals, blood, storms and water tend to begin in early childhood, whereas phobias
of heights tend to begin in the teens, and phobias of the situational type
(e.g., claustrophobia) begin even later, with mean ages at onset in the late
teens to mid-dle twenties.
The issue of comorbidity is important for several reasons. First,
covariation among disorders provides valuable information about the nature of
specific disorders as well as the utility of current di-agnostic nomenclature.
For example, high rates of cooccurrence between two disorders could reflect
overlap in the definitions of two disorders (as may be the case with social
phobia and avoidant personality disorder) or shared etiological pathways. In
addition, comorbidity may have implications for treatment. For example, an
individual with social phobia who abuses alcohol might be less likely to
benefit from treatment for social phobia if the alcohol abuse affects
compliance with the social phobia treatment.
About 70% of individuals with blood phobias tend to have in-jection
phobias as well. In addition, numerous factor analytical studies have found
that blood-injection-injury phobias tend to cluster together as do animal
phobias, natural environment pho-bias and situational phobias. In other words,
having a phobia of one specific phobia type makes an individual more likely to
have additional phobias of the same type than of other types. However, the
clustering is not perfect and many studies show exceptions to this pattern. The
research on the classification of specific pho-bia types is inconsistent. For
example, in several of these stud-ies, height phobias tend to be associated
with situational phobias (e.g., claustrophobia), despite height phobias being
listed as an example of the natural environment type in DSM-IV.
Specific phobias tend to cooccur with other specific pho-bias. A recent
methodologically rigorous study found that 15% of patients with a principal
diagnosis of specific phobia also met criteria for another type of specific
phobia and that 33% of pa-tients presenting with a principal diagnosis of
specific phobia had additional symptoms that met criteria for an Axis I anxiety
or mood disorder (Brown et al.,
2001a). However, compared with individuals who have other anxiety disorders,
individuals with principal diagnoses of a specific phobia are less likely to
have additional diagnoses. Rather, specific phobias typically occur on their
own or as additional diagnoses of lesser severity than the principal diagnosis.
Studies confirm that specific phobias are a frequently occurring additional
diagnosis, particularly with other anxiety disorders. However, specific phobias
tend to occur less frequently in the context of other disorders such as
depression (and alcohol use disorders.
Whereas the above mentioned studies reflect “syndrome” comorbidity, one
can also discuss comorbidity at the “symptom” level. In other words, one can
examine the frequency with which specific fears are associated with disorders
regardless of whether they meet criteria for specific phobia. It appears that specific
pho-bias commonly occur as additional diagnoses, at both clinical and
subclinical levels.
Social anxiety is a feature of many disorders. Individuals with panic
disorder, obsessive–compulsive disorder, or eating disor-ders often avoid
social situations because of the possibility of being judged negatively if
their symptoms are noticed by oth-ers. However, to meet diagnostic criteria for
social phobia, one’s concerns must not be exclusively related to the symptoms
of another disorder. With this criterion in mind, social phobia still tends to
be associated with a variety of other DSM-IV disorders. Furthermore, unlike
specific phobias, social phobia is frequently associated with additional
disorders of lesser severity. One study conducted in two outpatient clinics in
a managed care setting found a comorbidity rate of 43.6% in patients with
generalized social phobia (Katzelnick et
al., 2001). In another study, almost 60% of patients with social phobia had
additional symptoms that met criteria for one or more additional diagnoses
(Sanderson et al., 1990). The most
frequently assigned additional diagnoses in
this study were specific phobias (25%), dysthymia (21%) and panic disorder with
agoraphobia (17%). The presence of comor-bid mood disorders has been associated
with a greater duration of social phobia as well as more severe impairment
before and after cognitive–behavioral therapy (CBT). Other studies have found
that panic disorder with or without agoraphobia, generalized anxiety disorder, major
depressive disorder and substance abuse are common additional diagnoses as
well. In one prospective study, an estimated relative risk ratio of 2.30 for
alcohol abuse or dependence was found in individuals with subclinical social
phobia relative to individuals without social phobia or subclinical social
fears, suggesting that individuals with subclinical social phobia were more
than twice as likely to develop alcohol use dis-orders than were individuals
without social phobia or subclinical social anxiety (Crum and Pratt, 2001).
As an additional diagnosis, social phobia is often assigned in patients
with panic disorder with agoraphobia, generalized anxiety disorder,
obsessive–compulsive disorder and major de-pressive disorder. Social phobia is
also common among patients with eating disorders and alcohol abuse. When social
phobia coexists with a mood disorder, substance abuse disorder, or another
anxiety disorder, the social phobia tends to predate the other disorder.
Treatment of these disorders should include com-ponents that address the social
phobia when both disorders occur together.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.